Industry News
A Surprising Culprit Behind Chemotherapy Resistance In Rare Cancer
Jul 04, 2012
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy. Multiple myeloma is a rare cancer of plasma cells in the bone marrow. Though the finding has no immediate benefit for patients, the scientists say it could help guide research into better treatments... Read More
A Surprising Culprit Behind Chemotherapy Resistance In Rare Cancer
Jul 04, 2012
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy. Multiple myeloma is a rare cancer of plasma cells in the bone marrow. Though the finding has no immediate benefit for patients, the scientists say it could help guide research into better treatments... Read More
New Way To Grow, Isolate Cancer Cells May Add Weapon Against Disease
Jul 04, 2012
The news a cancer patient most fears is that the disease has spread and become much more difficult to treat. A new method to isolate and grow the most dangerous cancer cells could enable new research into how cancer spreads and, ultimately, how to fight it... Read More
The Surprising Answer To Why Cancer Rate Increases With Age
Jul 04, 2012
Cancers are age-related, much more frequent in the old than in the young. A University of Colorado Cancer Center review published in the journal Oncogene argues against the conventional wisdom that the accumulation of cancer-causing mutations leads to more cancer in older people, instead positing that it is the changing features of tissue in old age that promote higher cancer rates in the elderly... Read More
Breast Cancer Response To Endocrine Therapy: Preclinical Imaging Of Progesterone Receptor Signals Usefulness Of Biomarker
Jul 04, 2012
Research published in the July issue of The Journal of Nuclear Medicine shows imaging progesterone receptor (PR) status also may be able to identify responders and nonresponders to endocrine therapy at an early stage... Read More
In Vitro Study Identifies Potential Combination Therapy For Breast Cancer
Jul 04, 2012
A study conducted at Boston University School of Medicine (BUSM) demonstrates an effective combination therapy for breast cancer cells in vitro. The findings, published in the July 2012 issue of Anticancer Research, raise the possibility of using this type of combination therapy for different forms of breast cancer, including those that develop resistance to chemotherapy and other treatments... Read More
Blocking Pathway To T-Cell Acute Lymphoblastic Leukemia-Initiating Cell Regeneration
Jul 04, 2012
Research suggests that patients with leukemia sometimes relapse because standard chemotherapy fails to kill the self-renewing leukemia initiating cells, often referred to as cancer stem cells. In such cancers, the cells lie dormant for a time, only to later begin cloning, resulting in a return and metastasis of the disease... Read More
Enlarged Brain Size, Autism, Epilepsy And Cancer Linked To Newly Found Gene Mutations
Jul 03, 2012
According to a study published online in Nature Genetics, researchers have identified three new mutations associated with megalencephaly (enlarged brain size), cancer, autism, hydrocephalus, skin growth disorders, epilepsy, and vascular anomalies... Read More
New Treatment For Breast Cancer Patients Cuts Radiotherapy Time In Half
Jul 03, 2012
Several breast cancer patients could be treated in half the time after research shows that accelerated whole breast irradiation after lumpectomy is an effective treatment for ductal carcinoma in situ (DCIS). The study is published in the International Journal of Radiation Oncology-Biology-Physics. DCIS is one of the most common forms of early stage and non-invasive forms of breast cancer... Read More
Effects Of Refusing Blood Transfusions After Cardiac Surgery
Jul 03, 2012
Although Jehovah's Witness patients do not believe in blood transfusions, their risk of surgical complications or death after heart surgery is not greater than patients who receive blood transfusions, say researchers. The study, conducted by Gregory Pattakos, M.D., M.S., of the Cleveland Clinic, Ohio, and his team, is published in Archives of Internal Medicine... Read More
Previous Page Next Page